AlphaStocks
3.3
Weak

GE HealthCare Technologies Inc. (GEHC)

Health Care / Health Care Equipment

S&P 500

$61.73

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

#971out of 1126 in Health Care

Is GE HealthCare Technologies Inc. a Good Investment in 2026?

GE HealthCare Technologies Inc. (GEHC) scores 3.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates GE HealthCare Technologies Inc. as Attractive. However, the Graham model rates it Caution — 42% above fair value. GE HealthCare Technologies Inc. currently trades below its estimated fair value of $86, suggesting potential upside. GE HealthCare Technologies Inc. ranks #971 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E13.6ROE20.5Market Cap28B

Estimated Fair Value

$86.2028% below

Fair value above market price. ROE of 20% signals strong profitability. P/E of 14x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

42% above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Attractive

Bottom half (rank 52%)

Frequently Asked Questions

Is GE HealthCare Technologies Inc. (GEHC) a good investment?
Based on AlphaStocks' composite analysis, GE HealthCare Technologies Inc. (GEHC) scores 3.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. ROE of 20% signals strong profitability. P/E of 14x is moderate for this quality level.
What is GE HealthCare Technologies Inc.'s Piotroski F-Score?
GE HealthCare Technologies Inc.'s Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is GEHC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $86, GEHC appears undervalued. The stock currently trades 28% below its estimated fair value. Fair value above market price. ROE of 20% signals strong profitability. P/E of 14x is moderate for this quality level.
How does GEHC compare to other Health Care stocks?
GE HealthCare Technologies Inc. ranks #971 out of 1126 stocks in the Health Care sector, placing it in the top 86% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about GEHC?
AlphaStocks evaluates GEHC using five proven investment models. Piotroski: Neutral; Buffett: Attractive; Graham: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 3.3/10.

Similar Stocks

Compare GEHC with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer